[出典] REVIEW "Challenges and opportunities with CRISPR activation in bacteria for data-driven metabolic engineering" Fontana J, Sparkman-Yager D, Zalatan JG, Carothers JM (U Washington, Seattle). Curr Opin Biotechnol 2020-06-26. CRISPRa/iはヒト細胞を含 ...
もっと読む
2020年07月
[レビュー] 眼疾患治療用CRISPR/Cas9ゲノム編集因子の眼局所へのデリバリー (経路とキャリア)および各種CRISPRツール
[リンクのみ] REVIEW "Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases" Yu W, Wu Z (National Eye Institute/NIH). Adv Drug Deliv Rev 2020-06-27. ...
もっと読む
[レビュー] CRISPR/Cas9ゲノム編集による耐病性バナナの作出・課題・展望
[リンクのみ] REVIEW "CRISPR/Cas9-based genome editing of banana for disease resistance" Tripathi L, Ntui VO, Tripathi JN (国際熱帯農業研究所, ナイロビ). Curr Opin Plant Biol 2020-06-27. ...
もっと読む
[レビュー] CRISPR/Cas9による男性不妊研究の進展
[出典] REVIEW "CRISPR/Cas9 in Male Factor Infertility" Cinà DP, Phillips D Flannigan R (U British Columbia). Curr Tissue Microenviron Rep 2020-06-26. CRISPR/Cas9 による精原幹細胞 (spermatogonial stem cells: SSCs)と受精卵前核での遺伝子編集を介して、GWAS ...
もっと読む
[レビュー] ヒト幹細胞とゲノム編集に拠る脆弱X症候群 (FXS)のモデル細胞樹立と病因変異修復
[出典] "Advances in Human Stem Cells and Genome Editing to Understand and Develop Treatment for Fragile X Syndrome" Zhao X, Bhattacharyya A (U Wisconsin-Madison). Adv Neurobiol 2020-06-24.FXSの病因は、脆弱X精神遅滞タンパク質 (Fragile X Mental Retardation ...
もっと読む